Literature DB >> 7082375

Reciprocal relationship between erythrocyte ATP and deoxy-ATP levels in inherited ADA deficiency.

H A Simmonds, R J Levinsky, D Perrett, D R Webster.   

Abstract

A reciprocal relationship between erythrocyte ATP and deoxy-ATP levels has been noted in an immunodeficient child with adenosine deaminase (ADA) deficiency during therapy with red cell transfusions. The sum of red cell ATP plus deoxy-ATP equalled the normal complement of ATP prior to any form of therapy. dATP, dADP and dAMP levels were found in the same ratio (10:1:0.1) as the adenine nucleotides ATP, ADP and AMP. Red cell ATP levels were low, not high or normal as found by others in ADA deficiency, but no deoxyadenosine nucleotides could be found in peripheral blood mononuclear cells. Erythrocyte ATP depletion has recently been identified as a serious consequence of anti-leukaemic therapy with ADA inhibitors; it may thus be an important but hitherto unrecognised contributing factor in the clinical expression of inherited ADA deficiency.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7082375     DOI: 10.1016/0006-2952(82)90325-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

1.  Effect of red cell transfusions, thymic hormone and deoxycytidine in severe combined immunodeficiency due to adenosine deaminase deficiency.

Authors:  E G Davies; R J Levinsky; D R Webster; H A Simmonds; D Perrett
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

2.  Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.

Authors:  A D Webster; H Ip; S Pereira
Journal:  Clin Exp Immunol       Date:  1982-12       Impact factor: 4.330

3.  Heterogeneity of biochemical, clinical and immunological parameters in severe combined immunodeficiency due to adenosine deaminase deficiency.

Authors:  G Morgan; R J Levinsky; K Hugh-Jones; L D Fairbanks; G S Morris; H A Simmonds
Journal:  Clin Exp Immunol       Date:  1987-12       Impact factor: 4.330

4.  Substrate inhibition of adenosine phosphorylation in adenosine deaminase deficiency and adenosine-mediated inhibition of PP-ribose-P dependent nucleotide synthesis in hypoxanthine phosphoribosyltransferase deficient erythrocytes.

Authors:  F F Snyder; C Dyer; J E Seegmiller; R M Goldblum; G C Mills; F C Schmalstieg
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

5.  Autoimmune dysregulation and purine metabolism in adenosine deaminase deficiency.

Authors:  Aisha Vanessa Sauer; Immacolata Brigida; Nicola Carriglio; Alessandro Aiuti
Journal:  Front Immunol       Date:  2012-08-27       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.